recall
saveAlembic Pharmaceuticals Limited recall (Cls III)
January 14, 2026updated 5mo ago
community read0 votes
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30 — Reason: Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. — Status: Ongoing
view source ↗Data sources
last refreshed 31m ago
Found something off?
same company · ±60 days · 6
- approvalALDACTAZIDE: IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJan 14, 2026
- approvalDIFLUPREDNATE: DIFLUPREDNATE — FDA approvalJan 26, 2026
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalJan 30, 2026
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalJan 30, 2026
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalJan 30, 2026
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalJan 30, 2026
🐶 often sniffed alongside
top 8- tagRecall15 co-mentions · 5 sources
- drugElyxyb6 co-mentions · 1 sources
- drugCELECOXIB6 co-mentions · 1 sources
- drugcelecoxib SR6 co-mentions · 1 sources
- drugCelebrex6 co-mentions · 1 sources
- drugfesoterodine fumarate ER6 co-mentions · 2 sources
- drugtadalafil3 co-mentions · 1 sources
- drugdoxepin hydrochloride3 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that